Samira Sakhia
Tracked across 1 events · 6 articles · First seen Aug 20, 2026 · Last active Aug 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Knight Therapeutics Inc. announced the launch of WYNZORA, a topical cream for psoriasis vulgaris, in Canada. WYNZORA is a fixed-dose combination of calcipotriol and betamethasone dipropionate, developed by MC2 Therapeutics using its PAD Technology platform.…
Impact: Samira Sakhia, CEO of Knight Therapeutics, announced the launch and highlighted its strategic importance.
Aug 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Samira Sakhia live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard